Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A vial of liquid on a workbench in a pharmaceutical lab

Jul 17, 2026

Katalyze AI Raises $10.5M to Bring Agentic AI Systems to Pharmaceutical Manufacturing

Katalyze AI has successfully secured $10.5 million in seed funding aimed at developing an advanced operating system designed specifically for pharmaceutical manufacturing.This San Francisco-based startup, founded by Reza Farahani and others, focuses on creating specialized AI agents that leverage verified operational data, distinguishing itself from traditional general-purpose AI models. Their innovative platform is engineered to integrate various data sources, including Manufacturing Execution
Flat design illustration of a drug compound and clinical trial symbol

Jul 17, 2026

How well are AI-discovered drugs faring in the clinic?

The integration of AI in drug discovery is still in its nascent stages, with mixed results in clinical trials. While AI has the potential to revolutionize the pharmaceutical landscape, the journey from AI-driven discovery to clinical success is fraught with challenges.AI has emerged as a promising tool for accelerating drug research and development, traditionally a lengthy and expensive process. Although some AI-discovered drugs have shown early promise in phase 1 trials, their performance in la
Flat silhouette of a digital therapeutic device

Jul 17, 2026

United States Software as a Medical Device (SaMD) Market Set

The Software as a Medical Device (SaMD) market in the United States is projected to experience significant growth, reaching an estimated USD 29.80 billion by 2033, up from USD 6.26 billion in 2025. This expansion is driven by the increasing demand for digital therapeutics and AI-enabled healthcare solutions.The market is expected to grow at a compound annual growth rate (CAGR) of 20.6% from 2026 to 2033. Key factors contributing to this growth include the rising adoption of software solutions by
A smartphone on a table showing a health monitoring app in a cozy living room setting.

Jul 17, 2026

United States Digital Biomarkers Market Forecast to Reach US$

The Digital Biomarkers Market in the United States is projected to grow significantly, reaching approximately $39.28 billion by 2033, driven largely by advancements in neurological disease monitoring and AI analytics.The market, valued at $6.18 billion in 2025, is expected to expand at a compound annual growth rate (CAGR) of 22.7% between 2026 and 2033. This growth is fueled by the increasing adoption of digital biomarkers among healthcare providers, pharmaceutical companies, and research organi
Cloud and data representation

Jul 17, 2026

New report shows European LIS market trends

A recent report on the European Laboratory Information System (LIS) market forecasts significant shifts toward AI-driven and cloud-based solutions from 2026 to 2031, indicating a response to the evolving needs of modern laboratories.The report emphasizes a critical transition from traditional LIS platforms, which were designed for text-heavy data and manual inputs, to advanced systems capable of managing complex datasets required for remote diagnostics and digital pathology. As healthcare system
A minimalist representation of a lead atom and target symbol in dark colors.

Jul 17, 2026

Radiopharma firm AdvanCell raises $315m, and other financings

AdvanCell, a clinical-stage radiopharmaceutical company, has successfully raised $315 million in a Series D financing round, aimed at advancing its lead prostate cancer treatment into phase 3 trials.This oversubscribed round, led by Ally Bridge Group and Alpha Wave, will support the development of ADVC001, a PSMA-targeted radioligand therapy utilizing lead-212. The treatment has shown promising results in phase 2 trials for metastatic prostate cancer, achieving a 100% overall response rate witho
AI-powered image screening device in a hospital examination room

Jul 17, 2026

Commission makes €63.2 million available to support AI innovation in health and online safety

The European Commission has announced the availability of €63.2 million to foster AI innovation in health and online safety, reflecting a strategic push towards enhancing digital services across Europe.This funding initiative includes a significant allocation of €9 million aimed at advancing AI-powered image screening technologies in medical facilities, which holds promise for improving the early detection and diagnosis of critical health issues like cancer and cardiovascular diseases. Additiona
A petri dish with a vaginal microbiome sample in a dimly lit lab setting.

Jul 17, 2026

Juno Bio secures US$3.8m for precision diagnostics

Juno Bio has successfully raised US$3.8 million to enhance its diagnostics platform focused on vaginal health and reproductive care.This funding round, led by Ada Ventures and supported by Artesian, Entrepreneur First, and Illumina Accelerator, aims to facilitate the establishment of Juno Bio's first CLIA-certified sequencing laboratory in Oakland, California. The startup plans to launch a new clinical test that examines the vaginal microbiome and screens for common sexually transmitted infectio
A minimalist representation of a biological sample in a dark color scheme.

Jul 17, 2026

Antwerp’s Sightera Biosciences raises €3 million to scale its patient-derived AI drug discovery platform

Sightera Biosciences, a startup based in Antwerp, has successfully secured €3 million in pre-Seed funding to enhance its AI-driven drug discovery platform, which focuses on patient-derived biological data. This financing round was led by Entourage, Anacura, and QBIC, and the company aims to expand its team and accelerate the development of its oncology and fibrosis programs.The innovative approach of Sightera lies in its unique training methodology for its AI models. Instead of relying on generi
Silhouette of a regulatory figure with a checkmark, symbolizing approval in AI adoption.

Jul 17, 2026

What Pistoia Alliance's AI Poll Reveals About Industry Readiness And Regulatory Confidence

The Pistoia Alliance's recent poll conducted during the Clinical Trials Technology Congress sheds light on the industry's readiness for AI adoption and the regulatory landscape surrounding it.In a live audience poll at the Congress, regulators from various European agencies gathered insights on the industry's sentiment toward AI in clinical research. The results highlighted significant barriers to AI adoption, including trust and regulatory uncertainty, while also indicating that the regulatory
Emerging biotech city skyline at dusk

Jul 17, 2026

How BIO-Europe is expanding beyond dealmaking in 2026｜Beyond Biotech

The landscape of biotech hubs is shifting, with emerging cities poised to challenge established centers like Boston and San Francisco. In a recent discussion, reporter Will Maddox highlighted key insights from a special report on the evolving global biotech scene, particularly looking ahead to 2026.Historically, Boston and San Francisco have dominated the biotech industry, but new contenders are rising due to factors like lower costs and strategic government support. Maddox emphasizes that upcom
Flat illustration of a portable diagnostic device and test strip on a solid background.

Jul 17, 2026

Point of Care Testing Market to Reach USD 56.5 Billion by 2035 |

The Point of Care Testing (POCT) market is on track to nearly double in size, projected to reach USD 56.5 billion by 2035, driven by rapid advancements in diagnostic technology and an increasing demand for immediate healthcare solutions.The global POCT market is forecasted to grow from USD 26.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. This surge is attributed to the rising prevalence of chronic and infectious diseases, the shift towards decentralized healthcare, and innov